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Introduction: Animal-assisted therapy is deﬁned as the positive interaction between an animal and a patient
within a therapeutic framework. Previous studies have reported on the beneﬁcial eﬀects of animal-assisted
therapy with patients suﬀering from anxiety, a major challenge for professionals caring for patients with in-
tellectual disability. The presence of psychiatric comorbidities such as depression or anxiety within this popu-
lation is two to four times higher than in the general population. Finding new treatment options for such anxiety
disorders is important. The aim of this observational study was to explore whether the level of anxiety decreased
when a dog was present during therapy for people with learning disability.
Method: This was an observational study which involved 53 adult patients with mild learning disabilities (26
men) average age, 36.5 ± 11.2 years.
The State-Trait Anxiety Inventory (STAI) was completed by participants with the therapist, before and after
two 30-min therapeutic sessions, one in the presence of a dog and the other with only the therapist.
Results: The STAI score signiﬁcantly decreased after the session with the dog, which was not the case after the
session without the dog). After the animal-assisted session, the STAI score was signiﬁcantly lower (Z =−4.654;
p < 0.0001), which was not the case for the session without the dog (Z =−1.054; p = 0.295). There was a
signiﬁcant diﬀerence in anxiety between men and women.
Conclusion: Results suggest that there are positive beneﬁts of animal-assisted therapy for individuals with
learning disabilities which require conﬁrmation in a randomized controlled trial.
1. Introduction
Anxiety disorders represent a major challenge for the therapy teams
and the families who care for individuals with learning disabilities. This
group is very diﬃcult to treat, and existing methods to help them are
very limited.
This kind of disorder principally manifests itself through a more or
less acute concern regarding certain activities perceived as stressful or
challenging. But it can also manifest during therapy sessions meant to
confront the challenges of daily life or social relationships, which will
reduce the therapy’s eﬀectiveness. Generalized anxiety can lead to be-
havioral problems like agitation, irritability, tiredness, muscle tension,
lowered concentration level and diﬃculties in sharing attention with a
speaker. For individuals suﬀering from anxiety disorders, therapeutic
measures generally involve the combination of an anti-anxiety medi-
cation and therapeutic support. As highlighted by Hoﬀman, Hyung Lee
et al. [1], discussions surrounding the clinical eﬀects of these medicines
raised the necessity of ﬁnding alternative and additional treatments to
medicine-based treatments. Previous studies have shown that domestic
animals make it possible to decrease an individual’s stress and anxiety
level. A pilot study demonstrated that a 15-min interaction with a dog
signiﬁcantly reduced patient anxiety [2]. Going beyond this beneﬁt,
other authors have discovered that the presence of a dog leads to
lowered blood pressure and a decrease in the level of cortisol in stressed
patients [3–6]. Individuals with mental retardation also have diﬃculty
communicating, something which hinders their care. Traditional
therapies only partially improve the situation of these individuals, be-
cause they often rely on verbal communication [7], something that
animal-based therapy can work around [8].
Animal-assisted therapy (AAT) seems to be a particularly attractive
method for helping individuals suﬀering from anxiety disorders. Animal
therapy is deﬁned as the deliberate inclusion of a trained animal in a
treatment and whose goal is to achieve results that are diﬃcult to ob-
tain in another way and facilitated through the interaction with the
animal [9]. The use of a dog is not insigniﬁcant. Indeed, dogs have been
protecting humans for more than 15,000 years, something which oﬀers
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a feeling of security and comfort [1], and which is not necessarily found
in traditional therapy techniques. Often perceived as “man’s best
friend”, the animal’s spontaneous enthusiasm for social interactions
provides a substantial stimulus for the individual’s social behavior. The
presence of the dog facilitates communication between the therapist
and the patient, which increases their positive interactions. Numerous
studies have shown the eﬀectiveness and usefulness of animals in
therapy, but AAT does more than that. AAT seems too particularly in-
terest patients [2]. More than just helping the person calm down and
develop social behaviors, the animal provides a source of motivation.
Nimer and Lundahl’s [10] meta-analysis demonstrated that the ef-
fect size of AAT was 0.35 for well-being, 0.63 for behavior and 0.93 for
medical, for individuals with a mental diagnosis who were treated with
AAT compared to those with a mental diagnosis who did not receive
AAT. Kamioka et al. [11] and Kruger and Serpell [12], have aﬃrmed
that animals are a useful addition to therapy to diminish anxiety. For
many patients, having a session with a therapist is a stressful experience
and the presence of a dog tends to calm this stress and reduce anxiety.
The animal is then used as a way of turning the patient’s attention away
from the anxiety-producing situation. Finally, Berget et al. [13] indicate
in their article that a decrease of anxiety is visible in the six months
following AAT, but not immediately for the population studied. For our
population, no study has yet been conducted on patients with in-
tellectual disability and anxiety. Individuals living with mild learning
disabilities deserve the development of new psychotherapeutic methods
that are adapted to their possibilities. They are aware, in a more or less
frustrating way, of what challenges them or worries them in a given
existential situation. As we have seen, AAT oﬀers an interesting alter-
native support. Based on the study by Hoﬀman, Hyung Lee et al. [1] as
inspiration, we wanted to test the eﬀects of a playful interaction with a
dog within the framework of a basic therapy support situation with
individuals living with a mild learning disabilities. The support situa-
tion involves therapeutic interviews oriented toward problem-solving.
The goal of the research was thus to verify, within the framework of a
standard therapeutic intervention, how much can mediating the process
of entering a relationship through interactions with a dog produce a
measurable soothing of the patient’s anxiety. Hoﬀman, Hyung Lee et al.
[1] discovered that AAT reduced anxiety levels in patients suﬀering
from depression even more than classic therapy. We wanted to verify
whether the same result could be found working with a population of
patients with mental disabilities. Our hypothesis was that the level of
anxiety would decrease when a dog was present during therapy.
2. Patients and methods
2.1. Patients
We were interested in a patient group with intellectual disability. A
total of 60 people were approached and only 7 refused to take part in
the study. Of the 53 adult patients, 26 men and 27 women
(36.5 ± 11.2 years), 13 patients, lived in the family home and 40
patients were living in a unit belonging to a specialized institution. All
came with a carer or a parent.
All participants were diagnosed by a psychologist and received the
diagnosis of having mild learning disabilities, meaning an IQ between
50 and 70 (mild mental retardation according to the CIM-10: F70), and
were under regular outpatient treatment at the Section of Psychiatry of
Mental Development (SPDM) at the University Hospital Center, Vaud
(CHUV). They also presented with symptoms of generalized anxiety
(generalized anxiety disorder according to CIM-10: F41.1) as diagnosed
by a psychiatrist. No patient was having medication during the study.
Thus, our inclusion criteria were that the individual had both an in-
tellectual disability and an anxiety disorder. Exclusion criteria were dog
phobia or an allergy or aversion to dogs. The degree of intellectual
disability was determined using the Wechsler Intelligent Scale for Adult
(WAIS-IV). In order to measure anxiety, we used the STAI, the State-
Trait Anxiety Inventory by Spielberg [14].
2.2. Procedures
For this study, we used a single-subject design in which the subject
group was its own control group. In the article by Hoﬀman & et al., the
sample studied involved 12 participants. We wanted to increase the
sample (n = 53), which would provide a suﬃcient sample size for the
Wilcoxon test. (Indeed, according to the Wilcoxon tables, a large sample
is superior or equal to 25.)
The protocol for the clinical study was written based on the same
methodology as Hoﬀmann but adapted to our population [1]. The
protocol (n° 285/13) entitled “Animal-assisted therapy used for anxiety
disorder in patients with learning disabilities” was approved by the
Swiss Ethics Committee (CER-VD and Swissmedic nb 285/13, 09/25/
2014). Prior to participation in the evaluation, written consent was
obtained from the participant’s legal representative. Individuals were
well known to the author and, in the opinion of the authors, had a
receptive language suﬃcient to understand the instructions. Patients
could not give their written consent, but they agreed orally to partici-
pate in the study. The etiology of intellectual disability was not ex-
amined.
The dog used was a border collie trained for this purpose (Fig. 1).
The dog and the therapist were trained by the Swiss Romande Cynology
Federation (authorization nb OVF 08/0008). An authorization request
to use the dog on site at the Cery Hospital was made to the direction of
the CHUV. The STAI was usable within the framework of our research,
as our target population was comprised of individuals whose learning
disabilities only moderately inhibited verbalization and comprehension
capacity. The STAI is a self-evaluation, it is generally ﬁlled out by the
subject with the therapist’s help. In consideration of our patients’ mild
learning disabilities, the diﬀerent questions are formulated and ex-
plained orally by the researcher who collected responses during a semi-
structured interview. Data collection was conducted in a way to ensure
the patient’s anonymity.
2.3. Intervention
Sessions were organized always for the same hour. The session with
the dog and the therapist was organized as follows. When the patient
arrived in the waiting room, the patient was led into an interview room
to ﬁll out the STAI together. The questions were formulated orally so
that the patient could understand the meaning of the questions. If the
question was poorly understood, the question was reformulated by the
therapist. Once the questionnaire was completed, the patient selected
the activity that he wanted to do with the dog: play ball with the dog,
pet the dog or brush it. During this activity, the therapist intervened to
ask questions related to dogs, related to the patients experience with
animals in general and the like in order to see if the activity was
Fig. 1. “Doudou”, the dog used for animal-assisted therapy.
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working well. The patient was given a choice to remain in the interview
room with the animal or go out into the garden arranged for this pur-
pose in front of our oﬃces. At the end of 30 min, the therapist ended the
activity and ﬁlled out the questionnaire again with patient. During this
time, the dog remained lying down in the interview room. For the
session with only the therapist, a calm habitual interview was con-
ducted for 30 min. In this situation, the therapist encouraged the pa-
tient to speak about his or her physical and psychological health. Like
the session with the dog, the STAI was completed before and after the
interview with the patient, in the form of a semi-structured interview.
2.4. Statistical analyses
The Wilcoxon signed-rank test was used in order to evaluate the
inﬂuence of the interaction?with the dog. Results are presented as
averages ± a standard deviation. Analyses were conducted on a
computer using a statistical program (Statview 5.0). A value of
p < 0.05 was considered signiﬁcant. In order to calculate the eﬀect
size, we calculated Cohen’s d [15].
3. Results
At the time of the study, all patients were undergoing a regular
outpatient treatment at the SPDM of the CHUV for mild learning dis-
abilities and symptoms of generalized anxiety. No participant was ex-
cluded according to the exclusion criteria. Patient IQ was 61.7 ± 6.1.
The average for the STAI score before the control session was
57.5 ± 7.9 and 55.8 ± 7.9 after the control session. For the animal-
assisted session, the STAI score was 54.6 ± 7.4 before the session and
47.2 ± 8.9 after the session. After the animal-assisted session, the STAI
score was signiﬁcantly lower (Z = –4.654; p < 0.0001), while it re-
mained statistically unchanged for the control group (Z = –1.054;
p= 0.295) (Fig. 2). This meant that we achieved an eﬀect size of 0.22
for the control session, which indicated a weak eﬀect of the therapy on
the anxiety level. For the animal-assisted session, the eﬀect size in-
creased to 0.83, which meant that the eﬀect of the therapy with the dog
was strong. We also found a signiﬁcant diﬀerence between men and
women when the dog was present. The women had a STAI score of
49.7 ± 9.3 following the session with the dog, meaning an eﬀect size
of 0.73, while the men’s STAI score was 44.5 ± 7.7 after this session
(Z = 2.215; p= 0.031) (Fig. 3), for an eﬀect size of 1. No other sig-
niﬁcant diﬀerence between the men and women was found.
A supplementary analysis was performed comparing the STAI
measured after the ﬁrst session between the groups receiving ﬁrst the
AAT or the ordinary therapy. Comparing only the ﬁrst sessions in the
current design (the ﬁrst session attributed randomly to AAT or or-
dinary) is the equivalent of a randomized controlled study, and we can
perform ordinary tests to assess the eﬀect of AAT compared to the or-
dinary therapy. Such a comparison can be performed using a linear
regression adjusted for gender. A signiﬁcant improvement in STAI
among patients receiving AAT compared to ordinary therapy, con-
ﬁrmed the previous results. This analysis is presented in the Appendix
A.
The authors do not think it is necessary to employ the path analysis
in the current study, as the main question is the eﬀect of AAT compared
to the ordinary therapy and the direct or indirect eﬀect of therapy itself
is well established in the literature.
4. Discussion
Our study takes its inspiration directly from that of Hoﬀman et al.
[1], and it would be prudent to make a deeper comparison between
their results and ours. Table A1 summarizes the respective results from
each study. In our study, the patients had a higher anxiety score (STAI)
before the session, whether they were with the dog or not, than the
patients who took part in the study by Hoﬀman et al. This diﬀerence
was conserved after the session, and in both cases. It would be inter-
esting to compare the scores from the patients in Hoﬀman et al.’s study
(2009) to the scores from our patients, in order to determine whether
this diﬀerence is signiﬁcant. We can explain the increase in anxiety
disorders in the population living with learning disabilities by the fact
that numerous authors have indicated that co-morbidities are greater in
this population compared to the general population [16–18], which
could explain why our patients are more anxious than the patients of
the original study. According to the Inserm report (2016) [18], the co-
morbidities most associated with intellectual disability are “psychotic
disorders, mood disorders and anxiety disorders, personality disorders,
substance abuse, autism spectrum disorders, hyperactivity and atten-
tion deﬁcit syndrome” (p.290). According to epidemiological studies
cited in this report, anxiety disorders range between 1.7 and 17.4% in
individuals presenting with learning disabilities. This rate is 3 to 4 times
higher than in the rest of the population [19,20]. Another important
element highlighted was the p-value in the session with the dog. The p-
value in Hoﬀman et al.’s research (2009) already made it possible to
aﬃrm that the presence of the dog elicited a signiﬁcant decrease in
patient anxiety. The p-value in our study conﬁrms the dog’s therapeutic
contribution. It would thus seem that our patients were even more re-
ceptive to the presence of the dog than the patients in the original
study. These two diﬀerences can be explained by the greater number of
participants in our study (12 patients in the study by Hoﬀmann et al.
Fig. 2. Comparison of the results of the self-questionnaire on anxiety level (STAI) at the
beginning and the end of the session. There appears for all patients (men and women) a
signiﬁcant diﬀerence only in the presence of the dog (p < 0.0001) while it remains
unchanged without the dog. The power for the session in which the dog was present was
0.999 and for the session without the dog was 0.171.
Fig. 3. Comparison of the results of the self-questionnaire on anxiety level (STAI) be-
tween the men and the women. There appears a signiﬁcant diﬀerence in the presence of
the dog between men and women (p= 0.0031). The level of the men’s anxiety was more
signiﬁcantly reduced compared to the women.
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versus 53 patients in ours) and by the respective diagnoses of the pa-
tients in each study (major unipolar depression in the study by
Hoﬀman & al. versus slight learning disabilities in our study). (see for
more information, Table A1 in Appendix A)
Something that is particularly interesting to note in our results is the
diﬀerence between the average of the men’s STAI scores and the
average of the women’s STAI scores following the animal-assisted ses-
sion. Essentially, our results indicate that the men seem to be more
sensitive to the presence of the dog than the women, which manifests
itself by the men’s lower anxiety level after the session. The diﬀerence
of the STAI scores between the two groups before the animal-assisted
session was not signiﬁcant, which is a good indication that the men
beneﬁtted more from the dog’s presence during the session. A new
study would be necessary in order to ﬁnd an explanation to this dis-
covery.
The reason the dog brings about a decrease in anxiety seems to be
found in neurobiological mechanisms, and more precisely in the neural
endocrine system. Several studies indicate that this decrease is caused
by oxytocin, a neuropeptide secreted by the supraoptic and para-
ventricular nuclei of the hypothalamus [6,19,21–24]. Indeed, oxytocin
is known to have, among other things, an anti-stress eﬀect. When the
oxytocin level is high, the level of cortisol, the hormone responsible for
stress, is low. These two hormones provide a balance. Studies have
shown that when an individual interacts positively with a dog, even for
a limited amount of time, his or her oxytocin level increases, at least
temporarily, leading logically to a decrease in cortisol levels. This in-
crease is higher during a positive interaction with an animal than it is
with other relaxing activities, such as quietly reading a book. Another
factor must be taken into consideration. According to Walf and Frye
[25] and Li and Graham [26], women are more subject to mood dis-
orders and anxiety disorders than are men. Indeed, menstruation—a
period during which the level of estrogen in the body lowers—makes
women more susceptible to depression and to anxiety. After meno-
pause, this phenomenon leads to a twice higher risk of women devel-
oping one of these disorders. The hippocampus and the amygdala are
sensitive to estrogen. A ﬂuctuation of these hormones involves a
modiﬁcation of their activity. To sum up, a high level of estrogen leads
to a high activity level in these two regions, thus reducing anxiety and
depression. It would be interesting to see then, if the level of estrogen
changes during exposure to AAT.
A limitation of this study is that we did not have a control group. A
before and after study was conducted using subjects as their own con-
trols.
To conclude, our results are in line with those reported by Hoﬀmann
et al., who inspired us, and showed once again the beneﬁcial eﬀects of
using animals as a therapeutic intervention. These results also demon-
strated a signiﬁcant diﬀerence in anxiety levels between men and
women after a session with the dog. Thanks to the physiological ben-
eﬁts and from a dog’s connection and historical evolution alongside
humans, dogs are particularly suited to bringing an additional support
to patients in therapy. A dog makes it possible to create an indis-
pensable connection between the therapist and the patient, because
essentially, after exposure to the dog, the patient is more relaxed and
thus more able to take advantage of any therapeutic beneﬁts.
Future studies could look at the reasons why men beneﬁted more
from the presence of the dog compared to the women. It would also be
pertinent to determine if animal-assisted therapy has a major impact on
therapeutic treatment compared to a classic treatment. To determine
the eﬀect of TAA on anxiety symptomatology, randomized control
groups and a greater number of subjects should be used. Other objective
outcome measures such as the cortisol levels or blood pressure could be
used to conﬁrm changes at diﬀerent times throughout the day. In ad-
dition, it would be interesting to know if the decrease in anxiety could
be reduced and maintained over time. In this study, the subjective
nature of the outcome measure to evaluate anxiety could have been a
bias. Potentially, animal-assisted therapy coupled with cognitive be-
havioral therapy may confer beneﬁts more quickly compared to stan-
dard cognitive behavioral therapy.
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Appendix A
A linear regression model adjusted on the observed STAI scores after the ﬁrst session for each patient were compared between patients recieving
AAT at the ﬁrst therapy and patients with ordinary therapy. This result is adjusted for gender and age and seems to conﬁrm that AAT reduces the
STAI scores almost signiﬁcantly at the ﬁrst session.
1.> summary(lm(saitsum∼ factor(Setting) + factor(Sexe) + Age,data = all.data.after.ﬁrst.session))
Call:
lm(formula = saitsum∼ factor(Setting) + factor(Sexe) + Age, data = all.data.after.ﬁrst.session)
Residuals:
Min 1Q Median 3Q Max
−19.5924 −4.5824 −0.5754 3.4629 15.8843
Coeﬃcients:
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Estimate Std. Error t value Pr(> |t|)
(Intercept) 56.94522 3.55821 16.004 <2e-16 ***
factor(Setting)sc 4.02413 2.03407 1.978 0.0543.
factor(Sexe)masculin −5.36982 2.01755 −2.662 0.0109 *
Age −0.13508 0.09111 −1.483 0.1455
Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
Residual standard error: 6.886 on 43 ° of freedom
Multiple R-squared: 0.2324, Adjusted R-squared: 0.1788
F-statistic: 4.339 on 3 and 43 DF, p-value: 0.009308
The second and third models are linear mixed eﬀect models (Pinheiro J, Bates D, DebRoy S, Sarkar D and R Core Team (2017). _nlme: Linear and
Nonlinear Mixed Eﬀects Models_.R package version 3.1-131, URL: https://CRAN.R-project.org/package=nlme.), adjusted to measure the eﬀect of
AAT versus ordinary therapy on STAI scores measured at the end of each session for all sessions. The 3rd model is also adjusted for the STAI score
before each session. Both models are adjusted for intercorrelation among observations corresponding to the same individual by including a random
eﬀect on the subject levels.
2. > summary(model.adjusted.on.both.session.after < −lme(saitsum∼ factor(Setting) + factor(Sexe)
+factor(Protocole) + Age,data = all.data[all.data$Avant.après ==“après”,],random=∼1|Subject))
Linear mixed-eﬀects model ﬁt by REML
Data: all.data[all.data$Avant.après == “après”,]
AIC BIC logLik
662.4736 680.1261 −324.2368
Random eﬀects:
Formula: ∼1 | Subject
(Intercept) Residual
StdDev: 6.126199 5.171875
Fixed eﬀects: saitsum∼ factor(Setting) + factor(Sexe) + factor(Protocole) + Age
Value Std.Error DF t-value p-value
(Intercept) 48.58808 3.824713 49 12.703717 0.0000
factor(Setting)sc 8.30144 1.083490 43 7.661759 0.0000
factor(Sexe)masculin −3.79150 1.998469 49 −1.897202 0.0637
factor(Protocole)2 4.86195 2.008978 49 2.420111 0.0193
Age −0.05266 0.089760 49 −0.586660 0.5601
Correlation:
(Intr) fctr(St) fctr(Sx) fc(P)2
factor(Setting)sc −0.105
factor(Sexe)masculin −0.264 0.009
factor(Protocole)2 −0.357 −0.026 0.046
Age −0.883 −0.015 −0.004 0.102
Standardized Within-Group Residuals:
Min Q1 Med Q3 Max
−2.1717321 −0.4896794 0.1075124 0.5369745 2.4104667
Number of Observations: 97
Number of Groups: 53
3.> summary(model.adjusted.on.both.session.after.adj.avant < −lme(saitsum∼ factor(Setting)+
factor(Sexe) + factor(Protocole) + Age + staisum_avant,data = all.data.apres,random =∼1|Subject))
Linear mixed-eﬀects model ﬁt by REML
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Data: all.data.apres
AIC BIC logLik
591.2934 611.3803 −287.6467
Random eﬀects:
Formula: ∼1 | Subject
(Intercept) Residual
StdDev: 1.05702 4.676904
Fixed eﬀects: saitsum∼ factor(Setting) + factor(Sexe) + factor(Protocole) + Age + staisum_avant
Value Std.Error DF t-value p-value
(Intercept) −2.187265 4.529154 49 −0.482930 0.6313
factor(Setting)sc 5.926250 0.976687 42 6.067707 0.0000
factor(Sexe)masculin −0.751038 1.025123 49 −0.732631 0.4673
factor(Protocole)2 1.939223 1.023007 49 1.895610 0.0639
Age 0.031804 0.045217 49 0.703358 0.4852
staisum_avant 0.872599 0.069869 42 12.489128 0.0000
Correlation:
(Intr) fctr(St) fctr(Sx) fc(P)2 Age
factor(Setting)sc 0.098
factor(Sexe)masculin −0.311 −0.035
factor(Protocole)2 0.045 0.010 −0.022
Age −0.512 −0.052 0.011 0.059
staisum_avant −0.906 −0.201 0.235 −0.208 0.166
Standardized Within-Group Residuals:
Min Q1 Med Q3 Max
−4.5296909 −0.2416064 0.1265629 0.5241319 1.7077864
Number of Observations: 97
Number of Groups: 53
Models were adjusted using the R environment for statistical computing version 3.4.0 (ref: R Core Team (2017). R: A language and environment
for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/.) and fundamental assumptions
of each model were veriﬁed by graphical means.
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